Inactive Instrument

Company Canopy Rivers Inc Toronto S.E.

CA1380411084

RIV Capital Inc. is a Canada-based acquisition and investment company. The Company is focused on the United States (U.S.) cannabis market by acquiring, investing in, and developing operators and brands to create a multistate platform. The Company is a direct parent company of RIV Capital US Corporation and RIV Capital Corporation and exercises financial control over Etain, LLC. Through its strategic relationship with The Hawthorne Collective, Inc. (The Hawthorne Collective), a subsidiary of The ScottsMiracle-Gro Company (ScottsMiracle-Gro), the Company is The Hawthorne Collective's preferred vehicle for cannabis-related investments not under the purview of other ScottsMiracle-Gro subsidiaries. The Company's subsidiaries include 2683922 Ontario Inc., RIV Capital US Corporation, RIV Capital US Holdings LLC, RIV Capital US Real Estate LLC and RIV Capital US Services LLC.

Sales by Activity: Canopy Rivers Inc

Fiscal Period: March	2019 (CAD)	2020 (CAD)	2021 (CAD)	2022 (CAD)	2023 (USD)
U.S. Cannabis Platform	3.85Cr	1.22Cr	1.34Cr	18.96L	68.07L

See all business segments

Geographical breakdown of sales: Canopy Rivers Inc

Fiscal Period: March	2019 (CAD)	2020 (CAD)	2021 (CAD)	2022 (CAD)	2023 (USD)
United States	-	-	-	-	68.07L
Canada	3.85Cr	1.22Cr	1.34Cr	18.96L	-

See all geographic segments

Company details: Canopy Rivers Inc

RIV Capital, Inc.

40 King Street West

M5H 3Y2, Toronto

http://www.rivcapital.com/

Alternative Medicine

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ELI LILLY AND COMPANY	-0.61%	-3.43%	+36.07%	+117.61%	1,01900Cr
JOHNSON & JOHNSON	-1.02%	-5.60%	+35.72%	+64.82%	62TCr
ABBVIE INC.	+1.11%	-0.58%	+12.36%	+78.27%	46TCr
MERCK & CO., INC.	+0.34%	-3.01%	+61.79%	+41.79%	36TCr
ROCHE HOLDING AG	-0.95%	-4.05%	+20.54%	+40.33%	33TCr
NOVARTIS AG	-1.46%	-2.89%	+10.57%	+26.54%	27TCr
ASTRAZENECA PLC	-1.35%	-5.43%	-6.17%	+8.82%	24TCr
AMGEN INC.	-1.04%	-2.79%	+35.30%	+54.42%	22TCr
GILEAD SCIENCES, INC.	-1.87%	-4.10%	+28.44%	+97.54%	18TCr
Average	-0.76%	-3.39%	+26.07%	+58.90%	41.08TCr
Weighted average by Cap.	-0.60%	-3.33%	+29.07%	+71.15%